NCX-4016 has inhbitory effects on platelet cyclooxygenase and aggregability and is able to prevent monocyte activation ex vivo. NCX-4016 has a better gastric tolerability than aspirin

NO-Aspirin (NCX-4016) prevents platelet and monocyte activation inducing less gastric damage compared to aspirin

MINUZ, Pietro;MENEGUZZI, Alessandra;LECHI, Alessandro;
2004-01-01

Abstract

NCX-4016 has inhbitory effects on platelet cyclooxygenase and aggregability and is able to prevent monocyte activation ex vivo. NCX-4016 has a better gastric tolerability than aspirin
2004
NCX-4016; aspirin; platelet aggregation; tissue factor
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/335068
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 232
  • ???jsp.display-item.citation.isi??? 0
social impact